HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

SEGALL BRYANT & HAMILL, LLC's Holding History (CIK: 0001006378)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 307,224 Value ($000) $20,676 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 216,569 Value ($000) $15,883 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 310,830 Value ($000) $16,169 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 343,171 Value ($000) $21,898 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 353,103 Value ($000) $16,882 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 355,176 Value ($000) $20,330 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 305,320 Value ($000) $15,987 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 269,960 Value ($000) $10,982 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 242,470 Value ($000) $8,962 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 218,405 Value ($000) $8,343 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 263,088 Value ($000) $9,490 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 185,502 Value ($000) $7 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 186,854 Value ($000) $11 Avg Close $51.20 Range $39.17 - $59.46
Q4 2017
Shares 13,400 Value ($000) $271 Avg Close $18.38 Range $16.58 - $21.13
Q3 2017
Shares 13,400 Value ($000) $233 Avg Close $13.54 Range $11.41 - $17.62
Q2 2017
Shares 13,400 Value ($000) $172 Avg Close $13.36 Range $11.51 - $15.05
Q1 2017
Shares 13,400 Value ($000) $174 Avg Close $12.64 Range $9.68 - $15.20
Q4 2016
Shares 33,400 Value ($000) $330 Avg Close $10.95 Range $8.18 - $14.38
Q1 2014
Shares 11,000 Value ($000) $140 Avg Close $14.84 Range $11.28 - $18.18